This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against U...
BioNTech is spending up to £1 billion over the next ten years to boost its R&D a...
For some biotechs, the office is a place where scientists gather and pipelines a...
Plus, news about Genfit, Ipsen, Accropeutics, Merck KGaA, Alumis and Acelyrin: ...
Scientists from Weill Cornell Medicine in New York have announced the results fr...
Roche’s subsidiary Genentech is signing a second deal with Orionis Biosciences t...
PureTech Health’s tweaked form of Roche’s lung fibrosis drug Esbriet slowed lung...
Altos Labs, the massive but still relatively secretive $3 billion biotech, has f...
A Swiss biotech has secured $65 million to launch a trio of mid-stage trials for...
The "healthy lifespan" space is attracting more dollars. Juvenescence is out...
The FDA's Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genent...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has m...
The FDA's Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genent...
The gene editing company CRISPR Therapeutics struck a deal worth $95 million upf...
Senate Democrats grilled HHS Secretary Robert F. Kennedy Jr. on Tuesday over gap...